New stock news | Xinyi Semiconductor Hong Kong IPO prospectus has become invalid.
The Hong Kong stock prospectus submitted by Sinomicro Semiconductor Technology (Hangzhou) Co., Ltd. on June 30, 2025, will expire after 6 months on December 30, 2025, with Huatai International acting as its exclusive sponsor at the time of submission.
Semiconductor Technology Co., Ltd. (Hangzhou) (referred to as Semiconductor Technology) submitted its Hong Kong IPO prospectus on June 30, 2025, which expired on December 30, 2025, six months after submission, with Huatai International acting as its exclusive sponsor.
According to the prospectus, Semiconductor Technology is a leading power semiconductor company that provides efficient power management solutions through its proprietary process technology. The company operates under an innovative-driven Fab-Lite Integrated Device Manufacturer (IDM) business model.
The company's products cover three major technological areas: mobile technology, display technology, and power devices, widely used in: automotive industry; telecommunications equipment, including base stations and network communication devices; data centers, including AI servers; industrial applications, including motor drives, Battery Management Systems (BMS), green energy equipment, and humanoid Siasun Robot & Automation; consumer electronics products, including smartphones and televisions.
Related Articles

New stock outlook | Accounts receivable accounts for more than 60% of revenue, how can Youlesai tell a good story of circular packaging?

"Zootopia 2" breaks box office records and tops the animated film box office champion of Walt Disney Company(DIS.US).

The new national medical insurance list will be implemented starting today, benefiting patients with three innovative drugs from SKB BIO-B (06990).
New stock outlook | Accounts receivable accounts for more than 60% of revenue, how can Youlesai tell a good story of circular packaging?

"Zootopia 2" breaks box office records and tops the animated film box office champion of Walt Disney Company(DIS.US).

The new national medical insurance list will be implemented starting today, benefiting patients with three innovative drugs from SKB BIO-B (06990).






